Results 261 to 270 of about 10,169 (345)

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund, Johan Reutfors, Thomas Frisell, Fredrik Piehl   +3 more
wiley   +1 more source

Effects of a Mouthrinse Containing Silver Nanoparticles on Polymicrobial Oral Biofilms. [PDF]

Oral Health Prev Dent
Tomiyama K, Watanabe K, Iizuka J, Hamada N, Mukai Y.   +4 more
europepmc   +1 more source

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang, Lu Lu, Hui Gao, Qi Zhang, Jing Xiao, Josemir W. Sander, Weixi Xiong, Dong Zhou   +7 more
wiley   +1 more source

Food industry degrowth as a public health strategy: the case of ultra processed baked goods. [PDF]

Global Health
Campbell N, Browne S, Claudy M, Reilly K, Finucane FM.   +4 more
europepmc   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang, Jianli Zhao, Xue Zhao, Xiaowei Hu, Zichun Xiao, Jie Wu, Xiaowen Li, Jing Xu, Yu‐Jing Li   +8 more
wiley   +1 more source

Health Impact Database Development for Sweeteners and Sweetness Enhancers: The SWEET Project. [PDF]

Nutr Bull
Scott CE, Stamataki N, Harrold JA, Raben A, Halford JCG.   +4 more
europepmc   +1 more source

jv between Cargill and Evolva for sweetening agents

Focus on Catalysts, 2014
openaire   +1 more source

Effects of Xylitol-laced Sweets on the Accumulation of Dental Plaque : A Systematic Review and Meta-Analysis. [PDF]

Int Dent J
Mostafazadehbakhtiyary M, Majidinia S, Sohouli M, Chalakinia H, Langari AS, Ziaaddini S, Shakiba R, Yousefi S.   +7 more
europepmc   +1 more source

Artificial Sweetener Use in Hungary: A Cross-Sectional Study on Socioeconomic and Health Disparities from a Public Health Perspective. [PDF]

Nutrients
Ulambayar B, Móré M, Nagy AC.
europepmc   +1 more source

Assessment of the Efficacy of <i>Alstonia scholaris</i>, <i>Calotropis procera</i>, and Chlorhexidine Mouthrinses on Oral Health of Children Aged 9-12 Years: A Randomized Clinical Trial. [PDF]

Int J Clin Pediatr Dent
Valke PS, Shetty AJ, Naik SS, Kodical SR, Gore P, Band PS.   +5 more
europepmc   +1 more source